The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...

Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the UK over the next 10 years. The planned ...

Now, a team of scientists has developed a fresh approach: the first mRNA bird-flu vaccine for ... the first confirmed outbreak of the H5N1 avian influenza virus in dairy cattle was reported ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA announced new ...

mRNA vaccines offer clear advantages and disadvantages ... candidates for seasonal influenza and COVID-19 in Phase 2 and avian influenza in Phase 1 clinical development. Sanofi is developing ...

We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Moderna ...

Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...

We recently published a list of These 10 Firms Just Beat the Market Today. In this article, we are going to take a look at ...